Proactive Investors - Run By Investors For Investors

ICC International Cannabis says partner's Greek acquisition to bolster European capabilities

ICC will market and sell its cannabis and cannabidiol products throughout the 28 member states of the EU
Cannabis cultivation
International Cannabis engages in the cannabis business in Canada and internationally.

International Cannabis Corp (CSE:WRLD) (OTC:KNHBF) CEO Eugene Beukman said the acquisition by its European distribution partner, Cosmos Holdings Inc, of the Greek pharmaceutical wholesaler Cosmofarm Ltd will bolster ICC's distribution capabilities in Europe.

“International Cannabis applauds the acquisition of Cosmofarm, which further augments the company’s robust European distribution capabilities," Beukman said in a statement.

Cosmofarm is equipped with an extensive supplier network of 250 pharmaceutical manufacturers and had sales of nearly US$14 million for fiscal year 2017. It provides products to more than 1,300 pharmacies.

Cosmofarm is in the process of relocating its operations to a new 32,000-square-foot facility, greatly increasing its manufacturing capacities, according to ICC. The facility’s manufacturing operations include a robotic fulfillment center and will significantly improve Cosmofarm’s scaling and distribution capabilities.

READ: Cosmos Holdings acquires Cosmofarm in Greece

"Cosmofarm is a rapidly growing wholesaler with embedded shared-values of innovation and high-quality distribution," said Beukman. "The company will leverage Cosmofarm’s distribution channels and robotic fulfillment center to facilitate its growing pipeline of purchase orders in 2019."

Vancouver-based ICC will market and sell its cannabis and cannabidiol products throughout the 28 member states of the EU. 

Licenses permit the company to cultivate, manufacture, distribute and export industrial hemp and its many CBD-derived extracts. Greece boasts more than 300 days of sunshine per year, providing an attractive climate for outdoor industrial hemp cultivation, according to ICC.

Cosmos has a trans-European network of more than 160 clients and vendors.

ICC, through its subsidiaries, has agreements in place for European-based pharmaceutical distribution, wholesale importation, and research and development.

The company has licenses to cultivate, produce, distribute, store and export cannabis, cannabis derivatives and industrial hemp in Colombia, Denmark, Poland, Greece, Portugal, Poland, Macedonia, Bulgaria, South Africa and Lesotho.

 

Contact Rene Pastor by [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
A WeedMD greenhouse
January 21 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets
Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use